New hope for ALK lung cancer: targeted drug brigatinib tested in phase 2 trial
NCT ID NCT04318938
First seen Jan 11, 2026 · Last updated May 02, 2026 · Updated 19 times
Summary
This study tests the drug brigatinib in 118 adults with advanced ALK-positive non-small cell lung cancer. The goal is to see how long the drug can keep the cancer from growing. Participants take brigatinib as their first treatment, and researchers track tumor progression and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité Berlin
Berlin, Germany
-
Evangelisches Krankenhaus Hamm
Hamm, Germany
-
HELIOS Klinikum Emil von Behring
Berlin, 14165, Germany
-
KRH Klinikum Siloah Hannover
Hanover, 30459, Germany
-
Klinik Schillerhöhe
Stuttgart, Germany
-
Klinik der LMU München - Innenstadt
München, Germany
-
Klinikum Esslingen
Esslingen am Neckar, 73730, Germany
-
Klinikum Nürnberg
Nuremberg, 90419, Germany
-
Krankenhaus Nordwest Frankfurt
Frankfurt am Main, 60488, Germany
-
Lungenklinik Hemer
Hemer, Germany
-
Lungenklinik Köln - Merheim
Cologne, 51109, Germany
-
Medizinische Hochschule Hannover
Hanover, Germany
-
Niels-Stensen-Kliniken Georgsmarienhütte
Georgsmarienhütte, 49124, Germany
-
Pius Hospital Oldenburg
Oldenburg, 26121, Germany
-
Studiengesellschaft Hämato-Onkologie Hamburg
Hamburg, 20251, Germany
-
Thoraxklinik am Universitätsklinikum Heidelberg
Heidelberg, 69126, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany
-
Universitätsklinikum Gießen
Giessen, Germany
-
Universitätsklinikum Jena
Jena, 07740, Germany
-
Universitätsklinikum Leipzig
Leipzig, 04103, Germany
-
Universitätsklinikum Münster
Münster, Germany
-
Universitätsklinikum Regensburg
Regensburg, 93053, Germany
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
-
Universitätsklinikum Würzburg
Würzburg, Germany
-
Universitätsmedizin Essen
Essen, 45147, Germany
-
Universitätsmedizin Mainz
Mainz, 55131, Germany
Conditions
Explore the condition pages connected to this study.